Upper respiratory tract infection in children – immunostimulating treatment
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.011Keywords
viral infection, organism immunity, inosine pranobex, inosiplex, groprinosineAbstract
This paper is a review of publications on viral infections of the upper aerotract in children. Recurring infections can be a consequence of the lack of treatment, inappropriate therapy or accompanying diseases. It is possible that an impaired condition of immunity leads to recurring infections. In this review a great deal of attention has been given to the mechanisms and the various stages of viral infection, and the onset of an organism’s defense mechanisms against viruses. The function of the immunomodulatory and immunostimulatory medical product, namely inosine pranobex has been evaluated in in vitro and in vivo studies. A review of the antiviral activity of inosine pranobex and the onset of cellular and humoral immunity has been presented.
References
Albrecht P, Radzikowski A. Leczenie objawowe zakażeń dróg oddechowych dzieci. Standardy Med. 2001, 3: 6-35.
Jankowski A: Immunosupresyjne działanie antybiotyków. Ped. Pol 1990,9/10:90-95
Botulińska E. Hofman J, Tobolczyk J.: Wpływ rybosomów bakteryjnych na stan kliniczny I parametry immunologiczne u dzieci z nawrotowymi zapaleniami dróg oddechowych z odczynem bronchospastycznym. Pol. Merk. Lek. 2001, 59:353-356
Spisek R, Brazova J, Rozkova D, Zapletalova K, Sediva A, Bartunkowa J.: Maturation of dendritic cells by bacterial immunomodulators. Vaccine 2004,29,22:2768-2768
Jankowski A, Mleczko J.: Stosowanie immunostymulacji w nawracających zakażeniach dróg oddechowych u dzieci . Nowa Medycyna 2009,2:79-83
Albrecht P. Zasady leczenia przeciwgorączkowego, przeciwbólowego dzieci. Pediatria po Dyplomie wydanie specjalne, 2000: 14-19.
Chonmaitree T. Viral and bacterial interaction in acute otitis media. Pediatr. Infect. Dis. J. 2000,19: 24-30.
Matysiak M, Radzikowski A. Standardy postępowania przeciwgorączkowego
i przeciwbólowego. Standardy Medyczne 2000, 2: 18-35
Schlegel HG: Mikrobiologia ogólna. Warszawa: Wydawnictwo Naukowe PWN, 2003: 173-174
Witczak P, Brzezińska-Błaszczyk E.: Komórki tuczne w infekcjach wirusowych. Postępy Hig Med Dosw (online), 2012; tom 66: 231-241
Kadowaki N., Liu Y.J.: Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol., 2002; 63: 1126–1132
Takeuchi O., Akira S.: Innate immunity to virus infection. Immunol. Rev., 2009; 227: 75–86
Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., Hornung V.: Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci., 2010; 68: 765–783
Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A.: Pattern recognition receptors and the innate immune response to viral infection. Viruses, 2011; 3: 920–940
Kalesnikoff J., Galli S.J.: New developments in mast cell biology. Nat. Immunol., 2008; 9: 1215–1223
Zdziarska B.: Zespoły limfoproliferacyjne u chorych z przewlekłym zakażeniem wirusowym. Acta Haematologica Polonica 2009, 40, Nr 2, str. 451–453
Dębicka A.: Izoprinozyna w leczeniu wirusowego układu wzrokowego. Klin Oczna, 1987; 89, 308-309
Gołębiowska-Wawrzyniak M, Markiewicz K, Kozar A, Derentowicz P, Czerwińska –Kartowicz I, Jastrzębska-Janas K, Wacławek J, Wawrzyniak Z.M, Siwińska-Gołębiowska H.: Immunologiczne i kliniczne badania nad przydatnością terapeutyczną inozyny prano beks. Pol. Merk. Lek. 2005, 19,111,379
Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex.A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1986; 32: 383–424.
Femiano F, Gombos F, Scully C.: Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papilloma virus-related PVL. International Journal of Oral &Maxillofacial Surgery, 2001, 30: 318-322
Siwińska-Gołębiowska H, Piekarczyk A.: Pharmacological and toxicological Expert Report on Groprinosin , 2004, IMiD, Warszawa
. Ohnishi H, Kosuzume H, Inaba H, Okura M, Morita Y, Mochizuki H, Suzuki Y.: Mechanism of Host Defense Suppression Induced by Viral Infection: Mode of Action of Inosiplex as an Antiviral Agent. Infection and Immunity, 1982, 38,1:. 243-250
Khakoo R.A, Watson G.W, Waldman R.H, Ganguly R.: Effect of inosiplex (Isoprinosine)on induced human A infection. Journal of Antimicrobial Chemotherapy 1981, 7:389-397
Haskó G, Sitkovsky MV, Szabó C.: Immunomodulatory and neuroprotective effects of inosine TRENDS in Pharmacological Sciences 2004;.25, 3
Gomez, G. and Sitkovsky, M.V. :Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 2003, 102: 4472–4478
Morton A, Pacher P, Murthy KG, Nemeth ZH, Hascó G, SzaboC. Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Inter J Mol Med 2001,8: 617-621
Hasko, G. Kuhel DG, Németh ZH, Mabley JG, Stachlewitz RF, Virág L, Lohinai Z, Southan GJ, Salzman AL, Szabó C.: Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J. Immunol. 2000, 164, 1013–1019
Aydin OF, Enbil NS, Kuyucu N, Gürer Y.: Combined Treatment With Subcutaneous Interferon- Oral Isoprinosine, and Lamivudine for Subacute Sclerosing Panencephalitis Journal of Child Neurology 2003, 18, 2
Silin DS, Lyubomska OV, Ershov FI, Frolov VM, Kutsyna GA.: Synthetic and Natural Immunomodulators Acting as Interferon Inducers Current Pharmaceutical Design, 2009, 15, 1238-1247
Tsang KY, Fudenberg HH, Galbraith GMP, Donnelly RP, Bishop LR, Koopmann WR: Partial Restoration of Impaired Interleukin-2 Production and Tac Antigen (Putative Interleukin-2 Receptor) Expression in Patients with Acquired Immune Deficiency Syndrome by Isoprinosine Treatment In Vitro, J. Clin. Invest. 1985, 75: 1538-1544
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 858
Number of citations: 0
